Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

China · Delayed Price · Currency is CNY

30.05

+0.65 (2.21%)

Aug 21, 2026, 3:00 PM CST

SHA:688319 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	759.63	704.16	588.86	496.12	547.48	487.15
Revenue Growth	13.64%	19.58%	18.69%	-9.38%	12.38%	52.18%
Gross Profit	687.28	641	559.09	459.39	504.48	458.79
Operating Income	82.38	32.73	21.62	3.51	14.7	93.89
Net Income	-23.81	22.26	20.76	17.56	26.58	107.96
Earnings Per Share	-0.06	0.05	0.05	0.04	0.07	0.28
EPS Growth	-	7.23%	18.25%	-33.99%	-76.61%	182.95%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	235.28	249.21	241.66	362.07	359.23	454.37
Total Debt	524.1	433.03	361.79	237.61	134.03	38.25
Net Cash (Debt)	-288.83	-183.82	-120.13	124.47	225.2	416.11
Net Cash Growth	-	-	-	-44.73%	-45.88%	381.08%
Net Cash Per Share	-0.71	-0.45	-0.30	0.31	0.56	1.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	54.83	105.49	-9.73	44	-24.55	39.96
Capital Expenditures	-84.15	-98.81	-207.32	-169.88	-200.69	-69.71
Free Cash Flow	-29.32	6.68	-217.05	-125.88	-225.24	-29.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.48%	91.03%	94.94%	92.60%	92.14%	94.18%
Operating Margin	10.85%	4.65%	3.67%	0.71%	2.69%	19.27%
Pretax Margin	5.71%	4.53%	3.79%	3.15%	7.97%	22.00%
Profit Margin	-3.13%	3.16%	3.52%	3.54%	4.85%	22.16%
FCF Margin	-3.86%	0.95%	-36.86%	-25.37%	-41.14%	-6.11%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.038
Dividend Per Share Growth	-
Dividend Yield	0.24%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	462.46	207.29	365.54	211.50	134.42
Forward PE	-	187.85	98.61	60.77	38.44	59.68
P/FCF Ratio	-	1540.54	-	-	-	-
PS Ratio	16.05	14.62	7.31	12.94	10.27	29.79